Chargement en cours...
Global transcriptomic study of circRNAs expression profile in sorafenib resistant hepatocellular carcinoma cells
The anti-angiogenic drugs represented by sorafenib over the years have always been the first-line treatment of hepatocellular carcinoma (HCC), but the drug resistance has always been a "bottleneck" in curative effect. Recently, aberrant expression of circular RNA (circRNA) is considered to...
Enregistré dans:
| Publié dans: | J Cancer |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Ivyspring International Publisher
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7086252/ https://ncbi.nlm.nih.gov/pubmed/32226514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.39854 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|